| Role of mi R‐155 in the regulation of lymphocyte immune function and disease N Seddiki, V Brezar, N Ruffin, Y Lévy, S Swaminathan Immunology 142 (1), 32-38, 2014 | 212 | 2014 |
| Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression S Swaminathan, K Suzuki, N Seddiki, W Kaplan, MJ Cowley, CL Hood, ... The Journal of Immunology 188 (12), 6238-6246, 2012 | 180 | 2012 |
| Hypermobility and sports injuries in junior netball players R Smith, A Damodaran, S Swaminathan, R Campbell, B Les British Journal of Sports Medicine 39 (9), 628-631, 2005 | 171 | 2005 |
| Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma BY Kong, KP Micklethwaite, S Swaminathan, RF Kefford, MS Carlino Melanoma Research 26 (2), 202-204, 2016 | 95 | 2016 |
| The miR-9/Blimp-1/IL-2 axis is differentially regulated in progressive HIV infection N Seddiki, C Phetsouphanh, S Swaminathan, Y Xu, S Rao, J Li, ... European Journal of Immunology 43 (2), 510-520, 2013 | 62 | 2013 |
| Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral properties S Swaminathan, X Hu, X Zheng, Y Kriga, J Shetty, Y Zhao, R Stephens, ... Biochemical and biophysical research communications 434 (2), 228-234, 2013 | 61 | 2013 |
| Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific K Suzuki, T Ishida, M Yamagishi, C Ahlenstiel, S Swaminathan, K Marks, ... RNA biology 8 (6), 1035, 2011 | 61 | 2011 |
| Interleukin-27 Is a Potent Inhibitor of cis HIV-1 Replication in Monocyte-Derived Dendritic Cells via a Type I Interferon-Independent Pathway Q Chen, S Swaminathan, D Yang, L Dai, H Sui, J Yang, RL Hornung, ... PloS one 8 (3), e59194, 2013 | 58 | 2013 |
| Interleukin-15 (IL-15) strongly correlates with increasing HIV-1 viremia and markers of inflammation S Swaminathan, J Qiu, AW Rupert, Z Hu, J Higgins, RL Dewar, R Stevens, ... PLoS One 11 (11), e0167091, 2016 | 56 | 2016 |
| mi RNA s and HIV: unforeseen determinants of host‐pathogen interaction S Swaminathan, DD Murray, AD Kelleher Immunological reviews 254 (1), 265-280, 2013 | 50 | 2013 |
| Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility A Afrasiabi, GP Parnell, N Fewings, SD Schibeci, MA Basuki, ... Genome medicine 11, 1-13, 2019 | 49 | 2019 |
| The role of miRNAs in HIV-1 pathogenesis and therapy S Swaminathan, D Murray, AD Kelleher AIDS, 2012 | 49 | 2012 |
| Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection S Swaminathan, L Dai, HC Lane, T Imamichi Cytokine & growth factor reviews 24 (6), 571-577, 2013 | 37 | 2013 |
| The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis A Afrasiabi, GP Parnell, S Swaminathan, GJ Stewart, DR Booth Scientific reports 10 (1), 193, 2020 | 34 | 2020 |
| Vancomycin‐associated drug reaction with eosinophilia and systemic symptoms syndrome S Young, S Ojaimi, H Dunckley, MW Douglas, J Kok, DA Fulcher, MW Lin, ... Internal medicine journal 44 (7), 694-696, 2014 | 34 | 2014 |
| The Interaction of Human and Epstein–Barr Virus miRNAs with Multiple Sclerosis Risk Loci A Afrasiabi, NL Fewings, SD Schibeci, JT Keane, DR Booth, GP Parnell, ... International Journal of Molecular Sciences 22 (6), 2927, 2021 | 31 | 2021 |
| Does the presence of anti-HIV miRNAs in monocytes explain their resistance to HIV-1 infection? S Swaminathan, J Zaunders, J Wilkinson, K Suzuki, A Kelleher Blood 113 (20), 5029-5030, 2009 | 31 | 2009 |
| Gastric cancer screening in common variable immunodeficiency DK Van der Poorten, D McLeod, G Ahlenstiel, S Read, A Kwok, ... Journal of clinical immunology 38, 768-777, 2018 | 30 | 2018 |
| The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype JT Keane, A Afrasiabi, SD Schibeci, S Swaminathan, GP Parnell, ... EBioMedicine 71, 2021 | 28 | 2021 |
| miR-155 is differentially expressed in Treg subsets, which may explain expression level differences of miR-155 in HIV-1 infected patients N Seddiki, S Swaminathan, C Phetsouphanh, AD Kelleher Blood, The Journal of the American Society of Hematology 119 (26), 6396-6397, 2012 | 28 | 2012 |